ACON
Aclarion IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$7.78M
P/E Ratio
—
EPS
$-13.61
Beta
1.14
52W High
$12.03
52W Low
$2.34
50-Day MA
$3.05
200-Day MA
$5.99
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Aclarion Inc
Aclarion Inc (ACON) is an innovative healthcare technology company specializing in non-invasive diagnostic solutions that harness advanced data analytics and machine learning. By optimizing treatment pathways for musculoskeletal conditions, Aclarion delivers actionable insights derived from cutting-edge imaging techniques. Positioned at the forefront of the digital health sector, the company is addressing significant challenges in patient management while enhancing outcomes and reducing costs. Aclarion is well-positioned to capitalize on the growing demand for effective diagnostic tools in a dynamic healthcare landscape.
Fundamentals
| Revenue (TTM) | 75,730 |
| Gross Profit (TTM) | 6,830 |
| EBITDA | $-6.82M |
| Operating Margin | -10785.00% |
| Return on Equity | -104.80% |
| Return on Assets | -55.80% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $15.02 |
| Price-to-Book | 0.64 |
| Price-to-Sales (TTM) | 102.77 |
| EV/Revenue | 102.37 |
| EV/EBITDA | -0.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 80.60% |
| Shares Outstanding | $2.28M |
| Float | $2.04M |
| % Insiders | 10.69% |
| % Institutions | 0.91% |
Data last updated: 4/7/2026